Matches in Wikidata for { <http://www.wikidata.org/entity/Q93193220> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q93193220 description "article scientifique publié en 2020" @default.
- Q93193220 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q93193220 description "scientific article published on 01 May 2020" @default.
- Q93193220 description "wetenschappelijk artikel" @default.
- Q93193220 description "наукова стаття, опублікована 1 травня 2020" @default.
- Q93193220 description "գիտական հոդված հրատարակված 2020 թվականի մայիսի 1-ին" @default.
- Q93193220 name "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 name "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 type Item @default.
- Q93193220 label "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 label "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 prefLabel "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 prefLabel "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 P1433 Q93193220-1E514B71-196C-4153-A4DF-6EA482DAF08F @default.
- Q93193220 P1476 Q93193220-E7510972-A209-46B8-8DB7-94A656FE0F36 @default.
- Q93193220 P2093 Q93193220-129CBEF1-E0BC-4452-BF4C-B21868AEB74B @default.
- Q93193220 P2093 Q93193220-3E6CAD3A-6F61-42DA-A004-6F70DDC99CFD @default.
- Q93193220 P304 Q93193220-D997916A-49A6-417E-AA2D-F93B1E4356F9 @default.
- Q93193220 P31 Q93193220-9AF31E6D-0784-4F50-9140-08A4C4629E7F @default.
- Q93193220 P356 Q93193220-D09AF3D2-8925-4A4D-9A76-FDC04CD689A1 @default.
- Q93193220 P433 Q93193220-DFFA0701-173B-445F-9148-011F6E03692F @default.
- Q93193220 P478 Q93193220-57705BAC-BD7C-4981-86F4-BE13E2C435CD @default.
- Q93193220 P577 Q93193220-F22603D2-527E-463B-A44F-23818C29A052 @default.
- Q93193220 P698 Q93193220-F72451D6-AEBB-43E7-B563-7477451EE106 @default.
- Q93193220 P356 J.OPHTHA.2020.01.004 @default.
- Q93193220 P698 32327143 @default.
- Q93193220 P1433 Q7098109 @default.
- Q93193220 P1476 "Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)" @default.
- Q93193220 P2093 "Brian L VanderBeek" @default.
- Q93193220 P2093 "Nieraj Jain" @default.
- Q93193220 P304 "e35-e36" @default.
- Q93193220 P31 Q13442814 @default.
- Q93193220 P356 "10.1016/J.OPHTHA.2020.01.004" @default.
- Q93193220 P433 "5" @default.
- Q93193220 P478 "127" @default.
- Q93193220 P577 "2020-05-01T00:00:00Z" @default.
- Q93193220 P698 "32327143" @default.